Fabtech Technologies
NSE: FABTECH · ISIN INE0HF201011 · Healthcare
₹137.84−0.92 (−0.66%)
Monday 9 November, 12:56 IST. Delayed. Source: Yahoo Finance.
Price chart
₹137.84 −0.92 (−0.66%) today
The day
- Previous close
- ₹138.76
- Open
- ₹139.00
- Day high
- ₹142.72
- Day low
- ₹137.64
Listed on NSE since 7 October 2025.
Key numbers
- Market value
- ₹616.80 Cr
- P/E (trailing)
- 16.29
- EPS (trailing)
- ₹8.52
- Price to book
- 1.27
- Dividend yield
- 0.45%
- Debt to equity
- 0.17
- Profit margin
- 11.7%
- Volume today
- 47,912
- Average volume
- 1.01 L
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹193.80 Cr | ₹21.73 Cr |
| FY24 | ₹226.14 Cr | ₹27.22 Cr |
| FY25 | ₹322.46 Cr | ₹46.45 Cr |
| FY26 | ₹409.00 Cr | ₹38.36 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹92 Cr | ₹15 Cr | −46.5% |
| Q1 FY27Apr–Jun 2026 | ₹75 Cr | ₹4 Cr | – |
| Q4 FY26Jan–Mar 2026Audited | ₹159 Cr | ₹22 Cr | – |
| Q3 FY26Oct–Dec 2025 | ₹63 Cr | ₹-6 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹121 Cr | ₹28 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹68 Cr | ₹-6 Cr | – |
Source: Fabtech Technologies’s results filed with NSE, consolidated (the whole group). Net profit is the share of Fabtech Technologies’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹52 Cr | ₹55 Cr |
| Investments | ₹20 Cr | ₹26 Cr |
| Inventories | ₹18 Cr | ₹21 Cr |
| Owed by customers | ₹226 Cr | ₹204 Cr |
| Cash and equivalents | ₹170 Cr | ₹87 Cr |
| Total assets | ₹686 Cr | ₹654 Cr |
| Borrowings | ₹31 Cr | ₹43 Cr |
| Total liabilities | ₹247 Cr | ₹234 Cr |
| Shareholders’ equity | ₹439 Cr | ₹420 Cr |
Source: Fabtech Technologies’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.
About Fabtech Technologies
Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.
- Industry
- Health Information Services
- Based in
- Mumbai
- Employees
- 186
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Fabtech Technologies in the last day or two.
Dividends and corporate actions
All companies- Dividend - Re 0.60 Per Share
Dividend · ex-date 17 August 2026
Source: NSE. Latest first.
Information only, not investment advice. Prices are delayed.